NCT07451691

Brief Summary

This randomized controlled trial aims to evaluate the effects of the World Health Organization-based intrapartum care model on labour pain, labour comfort, childbirth satisfaction, and postpartum depression. The intrapartum care model emphasizes woman-centred, respectful, and supportive care throughout labour, promoting continuous support, effective communication, and active involvement of women in decision-making processes. Although this approach has been associated with improved labour experiences, including reduced pain, increased comfort and satisfaction, evidence from randomized controlled trials evaluating these outcomes together with postpartum depression in a comprehensive framework remains limited. This study seeks to provide high-quality evidence on the impact of the intrapartum care model on maternal childbirth experience and postpartum mental health.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2026

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 5, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

March 5, 2026

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2026

Completed
Last Updated

March 5, 2026

Status Verified

March 1, 2026

Enrollment Period

10 days

First QC Date

February 23, 2026

Last Update Submit

March 2, 2026

Conditions

Keywords

Labor PainChildbirthNormal VaginalMaternal Comfort

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale (VAS)

    Pain intensity was assessed using the Visual Analog Scale (VAS), a unidimensional pain measurement tool originally described by Price et al. (1983). The VAS consists of a 10-cm horizontal line, with the left endpoint labeled "0 = no pain" and the right endpoint labeled "10 = unbearable pain." Participants were asked to mark a point on the line that best represented the intensity of pain they perceived at that moment. The distance in centimeters from the "0" point to the marked point was measured and recorded as the pain intensity score. The scale ranges from 0 to 10, where higher scores indicate greater pain intensity (worse outcome). Pain severity was interpreted as follows: 0 = no pain, 2 = mild pain, 4 = moderate pain, 6 = severe pain, 8 = very severe pain, and 10 = unbearable pain. In this study, the Visual Analog Scale was administered at two time points: first, during the pregnant woman's initial admission to the maternity clinic in the latent phase

    60-120 minutes

Secondary Outcomes (2)

  • Birth Comfort Scale (BCS)

    60-120 minute

  • Birth Satisfaction Scale - Short Form (BSS-S)

    60 minuteShort Form of the Birth Satisfaction Scale (DMÖ-K)

Study Arms (2)

Experimental- WHO-ICARE Trial

EXPERIMENTAL

Participants in the intervention group will receive continuous, individualized, and woman-centred midwifery care based on the World Health Organization intrapartum care model throughout labour and childbirth. This intervention includes continuous physical and emotional support, effective communication, provision of timely information, encouragement of shared decision-making, respect for privacy and dignity, and avoidance of unnecessary medical interventions. Supportive care will be provided consistently from admission to the labour ward until the completion of childbirth.

Behavioral: WHO-ICARE Trial

control group

NO INTERVENTION

Participants in the control group will receive routine intrapartum care provided in the hospital in accordance with standard clinical practice. This care includes standard midwifery and obstetric services without the structured implementation of the World Health Organization-based intrapartum care model or continuous individualized supportive care. No additional intervention beyond routine care will be applied.

Interventions

WHO-ICARE TrialBEHAVIORAL

Participants in the intervention group will receive continuous, individualized, and woman-centred midwifery care based on the World Health Organization intrapartum care model throughout labour and childbirth. This intervention includes continuous physical and emotional support, effective communication, provision of timely information, encouragement of shared decision-making, respect for privacy and dignity, and avoidance of unnecessary medical interventions. Supportive care will be provided consistently from admission to the labour ward until the completion of childbirth.

Experimental- WHO-ICARE Trial

Eligibility Criteria

Age18 Years - 49 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age: 18 years and older
  • Gestational status: Term pregnancy

You may not qualify if:

  • those with psychological problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kahramanmaraş Sütçü İmama Universty

Kahramanmaraş, Kahramanmaraş, 46040, Turkey (Türkiye)

Location

Kahramanmaraş Sütçü İmama Universty

Kahramanmaraş, Kahramanmaraş, 461000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Labor Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • HATİCE GÜL ÖZTAŞ

    Kahramanmaraş sütçü imam

    STUDY DIRECTOR

Central Study Contacts

HATİCE GÜL ÖZTAŞ, DİRECTOR

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DR.

Study Record Dates

First Submitted

February 23, 2026

First Posted

March 5, 2026

Study Start

March 5, 2026

Primary Completion

March 15, 2026

Study Completion

March 15, 2026

Last Updated

March 5, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations